Article
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast…
eLife · 2023 · Elena Farmaki, author Aritro Nath, author Rena Emond, author Kimya L Karimi, author Vince K Grolmusz, author Patrick A Cosgrove, author Andrea H Bild, author ([email protected]) Yongliang Yang, editor Caigang Liu, senior_editor
Key facts
| Title | ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer |
|---|---|
| First author | Elena Farmaki, author Aritro Nath, author Rena Emond, author Kimya L Karimi, author Vince K Grolmusz, author Patrick A Cosgrove, author Andrea H Bild, author ([email protected]) Yongliang Yang, editor Caigang Liu, senior_editor |
| Journal | eLife |
| Published | Sep 29, 2023 |
| DOI | 10.7554/eLife.85898 |
| Devices mentioned | K040782, K973350, K990827 |
| Product codes mentioned | JAK, JLX, KQP, JJQ, JQW, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1